Skip to content
Riskpilot
← Back to search
Sign in
Get full access
75PHARMA OY
OY
Active
Y-tunnus 0703322-7
Mikonkatu 9, 00100
Helsinki
All other professional, scientific and technical activities n.e.c.
· NACE 7499
Est. 1988
0 employees
Watchlist
Share
Finland
/
Companies
/
All other professional, scientific and technical activities n.e.c.
/
75PHARMA OY
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
1M
2022
0M
2023
0M
2024
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
EUR thousands
Item
2020
2021
2022
2023
2024
Revenue
5
0
537
150
165
Staff expenses
—
−0
−160
−108
−8
EBITDA
−45
−204
18
24
66
Depreciation & amort.
—
—
—
−0
−0
EBIT
−45
−204
18
24
66
Net financials
−6
−4
−11
−20
−47
Profit before tax
−51
−208
7
4
18
Tax
−0
−0
3
−0
−0
Net profit
−51
−208
4
4
18
Balance sheet
EUR thousands
Item
2020
2021
2022
2023
2024
Total assets
353
437
1 134
342
779
Equity
−47
−255
−251
−247
−229
Long-term debt
400
356
311
0
0
Short-term debt
0
336
1 074
589
1 008
Total debt
400
692
1 385
589
1 008
Financial ratios
5-year trend
EBITDA margin
40.1%
This company
15.8%
Market median
+154% vs market
2020
2024
Equity ratio
-29.4%
This company
38.2%
Market median
-177% vs market
2020
2024
Return on equity
1844300.0%
This company
18.4%
Market median
+10023270% vs market
2020
2024
Net profit margin
11.2%
This company
8.1%
Market median
+38% vs market
2020
2024
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
2020
2024
Debt / equity
4.40×
This company
0.62×
Market median
-610% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
More on 75PHARMA OY
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network